Skip to content

Inspection Record

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy — FDA 483 Findings

US FDAPublished 2024-01-17 3 findingsOther quality system

Inspectors Bei Y HeThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.

2Other quality system

Visual inspection of finished drug products prior to distribution is not adequately performed.

3Other quality system

Non-sterile, low-shedding wipes are used to cleaned the ISO 5 hoods.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy findings history — including this company's other documentsAll US FDA findings US FDA documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.